Sign Up
Already have an account?Log In
By clicking "Sign Up" you agree to our terms of service and privacy policy
- Username should be more than 3 characters.
- Username cannot start with numeric character.
- Username characters must be from {a-z,0-9}, special characters are not allowed.
- Make sure the Email is working to receive verification code & password reset link.
- Password should be more than 6 characters.
Forgot Password
Neuralink
According to Bloomberg, Neuralink has initiated preliminary discussions to raise approximately $500 million in new funding at an estimated pre-money valuation of $8.5 billion. This move indicates a.....
Neuralink, the neurotechnology company founded by Elon Musk, is set to commence its human trials for brain implants designed to assist individuals with mobility, vision, or speech impairments. These.....
Elon Musk has been vocal about his startup, Neuralink, which aims to enhance human capabilities through advanced computer implants. However, China's ambitious brain implant project is set to.....
Neuralink, the brain implant company co-founded by Elon Musk, is taking significant steps towards shaping the future of brain-computer interfaces by filing for trademarks on several innovative product.....
Neuralink has made significant strides in innovative brain-computer interface technology, exemplified by a recent demonstration where users controlled a robotic arm directly with their thoughts. By.....
Elon Musks brain implant company is launching a new study to test whether its wireless device can control a robotic arm.
Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.
Elon Musk's Neuralink has received FDA clearance for its experimental Blindsight device, designed to restore vision by targeting the brain's visual cortex.
Neuralink, the Elon Musk-owned brain-computer interface company, on Tuesday received "breakthrough device" clearance from the FDA. But this does not mean
Since its announcement back in February, the Neuralink PRIME study has been investigating and evaluating the safety and efficacy of brain-computer interface (BCI) devices, along with the...
Neuralink has published an update on the second patient in its early human trials, and it said that "promisingly," it has "observed no thread retraction" in the participant.
In a livestreamed update on X, Elon Musk and Neuralink executives gave an update on the company's next study participantand its next-generation brain implant.